Abstract:ObjectiveDiabetic nephropathy (DN) is one of the most common causes of end-stage renal failure. The pathogenesis of progressive renal injury is multifactorial and the mechanism by which hyperglycemia causes microangiopathy is still poorly understood. The WNT pathway is activated in DN and regulating β-catenin protein levels is referred to as the canonical Wnt/β-catenin pathway. Because the renin angiotensin system has been reported to be an important contributory factor in the pathophysiology of DN, exogenous administration of angiotensin II receptor antagonist may be beneficial in counteracting some biochemical or functional changes of DN. The aim of the study was to determine the β-catenin expression and the possible protective effects of irbesartan, an angiotensin II type 1 receptor blocker (ARB) in a rat model of streptozotocin(STZ)-induced diabetic nephropathy.MethodsSTZ-induced DN in rats was assessed biochemically by measuring urine volume, protein and creatinine clearance as well as Kidney weight/body weight (KW/BW) and the index of mesangial expansion. Three groups of male Sprague-dawley rats were used. The first group consisted of non-diabetic control rats (control). The second group was the untreated diabetic rats(STZ+vehicle). The third group consisted of diabeti rats treated with irbesartan, 50 mg/kg for 12 weeks (STZ+irbesartan). Immunohistochemical stainings and real time PCR for β-catenin were performed in renal cortex of rat modals.ResultsMarked hyperglycemia, polyuria, proteinuria, renal hypertrophy, mesangial matrix expansion and glomerular hyperfiltration were observed in STZ diabetic rats. The levels of microalbuminuria and KW/BW in the STZ+irbesartan group were lower than those in the STZ+vehicle group (P<0.05). The up-regulated immunostaining and mRNA expression of β-catenin were decreased in renal cortic of the Irbesartan-treated diabetic group, but there was no significant difference compared to the untreated diabetic group.ConclusionThe data suggest that irbesartan ameliorates proteinuria and renal hypertrophy, charactered damages of STZ-induced early-stage DN in rats, but its effective drug target is not to inhibit the up-regulated expressions of β-catenin.

Simvastatin Ameliorates Low-Dose Streptozotocin-Induced Type 2 Diabetic Nephropathy In An Experimental Rat Model

Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.

The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-Induced Diabetic Rats

Metformin Ameliorates Diabetic Nephropathy in a Rat Model of Low-Dose Streptozotocin-Induced Diabetes.

Reno-protective effect of simvastatin through an anti-inflammatory mechanism in streptozotocin-induced diabetic rats

Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression

Protective effects and the mechanism of Rosuvastatin on type 2 diabetic rats

Simvastain's Renoprotection Effects and Its Influence on MCP-lmRNA Expression of Renal Tissue in STZ-induced Diabetic Rats

Effect of Simvastatin on expression and excretion of connective tissue growth factor in renal tissue and urinary of diabetic rats

The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats

Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats

Inhibition of Transdifferentiation of Renal Tubular Epithelial Cells by Simvastatin in Rats

Dapagliflozin can alleviate renal fibrosis in rats with streptozotocin‑induced type 2 diabetes mellitus

The Effect of Simvastatin on the Renal Protection and the Urinary VEGF Excretion in Diabetic Rats

Effects of Angiotensin-Ii Receptor Blockers on Β-Catenin Expression in a Rat Model of Experimental Streptozotocin-Induced Early-Stage of Diabetic Nephropathy

Statin Improved Endothelial Dysfunction in Experimental Diabetes Mellitus

The Effect of Simvastatin on the Urinary Protein Excretion of Diabetic Rats

Resveratrol Ameliorates Early Diabetic Nephropathy Associated with Suppression of Augmented TGF-β/smad and ERK1/2 Signaling in Streptozotocin-Induced Diabetic Rats.

Research on the Effect of Primary Prevention with Low-Dose Simvastain and Captopril to Rats with Diabetic Nephropathy

Effect of Simvastatin on the Renal Injury of Diabetic Rats and Excretion of Urine TGF-β1

Fenugreek Prevents the Development of STZ-Induced Diabetic Nephropathy in a Rat Model of Diabetes